Literature DB >> 9199333

Functional characterization of the transactivation properties of the PDX-1 homeodomain protein.

M Peshavaria1, E Henderson, A Sharma, C V Wright, R Stein.   

Abstract

Pancreas formation is prevented in mice carrying a null mutation in the PDX-1 homeoprotein, demonstrating a key role for this factor in development. PDX-1 can also bind to and activate transcription from cis-acting regulatory sequences in the insulin and somatostatin genes, which are expressed in pancreatic islet beta and delta cells, respectively. In this study, we compared the functional properties of PDX-1 with those of the closely related Xenopus homeoprotein XIHbox8. Analysis of chimeras between PDX-1, XIHbox8, and the DNA-binding domain of the Saccharomyces cerevisiae transcription factor GAL4 revealed that their transactivation domain was contained within the N-terminal region (amino acids 1 to 79). Detailed mutagenesis of this region indicated that transactivation is mediated by three highly conserved sequences, spanning amino acids 13 to 22 (subdomain A), 32 to 38 (subdomain B), and 60 to 73 (subdomain C). These sequences were also required by PDX-1 to synergistically activate insulin enhancer-mediated transcription with another key insulin gene activator, the E2A-encoded basic helix-loop-helix E2-5 and E47 proteins. These results indicated that N-terminal sequences conserved between the mammalian PDX-1 and Xenopus XIHbox8 proteins are important in transcriptional activation. Stable expression of the PDX-1 deltaABC mutant in the insulin- and PDX-1-expressing betaTC3 cell line resulted in a threefold reduction in the rate of endogenous insulin gene transcription. Strikingly, the level of the endogenous PDX-1 protein was reduced to very low levels in these cells. These results suggest that PDX-1 is not absolutely essential for insulin gene expression in betaTC3 cells. We discuss the possible significance of these findings for insulin gene transcription in islet beta cells.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9199333      PMCID: PMC232251          DOI: 10.1128/MCB.17.7.3987

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  63 in total

1.  Ultrastructural studies of early morphogenesis and cytodifferentiation in the embryonic mammalian pancreas.

Authors:  N K Wessells; J Evans
Journal:  Dev Biol       Date:  1968-04       Impact factor: 3.582

2.  Structure and evolution of the insulin gene.

Authors:  D F Steiner; S J Chan; J M Welsh; S C Kwok
Journal:  Annu Rev Genet       Date:  1985       Impact factor: 16.830

3.  Two related helix-loop-helix proteins participate in separate cell-specific complexes that bind the insulin enhancer.

Authors:  M S German; M A Blanar; C Nelson; L G Moss; W J Rutter
Journal:  Mol Endocrinol       Date:  1991-02

4.  Insulin cells of pancreas extend neurites but do not arise from the neuroectoderm.

Authors:  G Teitelman
Journal:  Dev Biol       Date:  1990-12       Impact factor: 3.582

5.  Analysis of E1A-mediated growth regulation functions: binding of the 300-kilodalton cellular product correlates with E1A enhancer repression function and DNA synthesis-inducing activity.

Authors:  R W Stein; M Corrigan; P Yaciuk; J Whelan; E Moran
Journal:  J Virol       Date:  1990-09       Impact factor: 5.103

6.  An inhibitory domain of E12 transcription factor prevents DNA binding in E12 homodimers but not in E12 heterodimers.

Authors:  X H Sun; D Baltimore
Journal:  Cell       Date:  1991-01-25       Impact factor: 41.582

7.  Transcriptional regulation of the human insulin gene is dependent on the homeodomain protein STF1/IPF1 acting through the CT boxes.

Authors:  H V Petersen; P Serup; J Leonard; B K Michelsen; O D Madsen
Journal:  Proc Natl Acad Sci U S A       Date:  1994-10-25       Impact factor: 11.205

8.  Firefly luciferase gene: structure and expression in mammalian cells.

Authors:  J R de Wet; K V Wood; M DeLuca; D R Helinski; S Subramani
Journal:  Mol Cell Biol       Date:  1987-02       Impact factor: 4.272

9.  Glucose modulates the binding activity of the beta-cell transcription factor IUF1 in a phosphorylation-dependent manner.

Authors:  W M MacFarlane; M L Read; M Gilligan; I Bujalska; K Docherty
Journal:  Biochem J       Date:  1994-10-15       Impact factor: 3.857

10.  Pancreatic beta-cell-type-specific transcription of the insulin gene is mediated by basic helix-loop-helix DNA-binding proteins.

Authors:  S R Cordle; E Henderson; H Masuoka; P A Weil; R Stein
Journal:  Mol Cell Biol       Date:  1991-03       Impact factor: 4.272

View more
  25 in total

1.  The homeodomain of PDX-1 mediates multiple protein-protein interactions in the formation of a transcriptional activation complex on the insulin promoter.

Authors:  K Ohneda; R G Mirmira; J Wang; J D Johnson; M S German
Journal:  Mol Cell Biol       Date:  2000-02       Impact factor: 4.272

2.  PRMT1 promotes glucose toxicity-induced β cell dysfunction by regulating the nucleo-cytoplasmic trafficking of PDX-1 in a FOXO1-dependent manner in INS-1 cells.

Authors:  Lixia Lv; Hewen Chen; Jiaying Sun; Di Lu; Chen Chen; Dongfang Liu
Journal:  Endocrine       Date:  2015-02-10       Impact factor: 3.633

3.  Insulin gene transcription is mediated by interactions between the p300 coactivator and PDX-1, BETA2, and E47.

Authors:  Yi Qiu; Min Guo; Suming Huang; Roland Stein
Journal:  Mol Cell Biol       Date:  2002-01       Impact factor: 4.272

4.  The NeuroD1/BETA2 sequences essential for insulin gene transcription colocalize with those necessary for neurogenesis and p300/CREB binding protein binding.

Authors:  A Sharma; M Moore; E Marcora; J E Lee; Y Qiu; S Samaras; R Stein
Journal:  Mol Cell Biol       Date:  1999-01       Impact factor: 4.272

5.  p300 mediates transcriptional stimulation by the basic helix-loop-helix activators of the insulin gene.

Authors:  Y Qiu; A Sharma; R Stein
Journal:  Mol Cell Biol       Date:  1998-05       Impact factor: 4.272

6.  Missense mutations in the insulin promoter factor-1 gene predispose to type 2 diabetes.

Authors:  W M Macfarlane; T M Frayling; S Ellard; J C Evans; L I Allen; M P Bulman; S Ayres; M Shepherd; P Clark; A Millward; A Demaine; T Wilkin; K Docherty; A T Hattersley
Journal:  J Clin Invest       Date:  1999-11       Impact factor: 14.808

7.  Defective mutations in the insulin promoter factor-1 (IPF-1) gene in late-onset type 2 diabetes mellitus.

Authors:  E H Hani; D A Stoffers; J C Chèvre; E Durand; V Stanojevic; C Dina; J F Habener; P Froguel
Journal:  J Clin Invest       Date:  1999-11       Impact factor: 14.808

8.  The pancreatic and duodenal homeobox protein PDX-1 regulates the ductal specific keratin 19 through the degradation of MEIS1 and DNA binding.

Authors:  Johannes von Burstin; Maximilian Reichert; Melanie P Wescott; Anil K Rustgi
Journal:  PLoS One       Date:  2010-08-19       Impact factor: 3.240

9.  Cell-specific cytotoxicity of human pancreatic adenocarcinoma cells using rat insulin promoter thymidine kinase-directed gene therapy.

Authors:  Thomas A Tirone; Xaio-Ping Wang; Nancy S Templeton; Tim Lee; Liz Nguyen; William Fisher; F Charles Brunicardi
Journal:  World J Surg       Date:  2004-08-03       Impact factor: 3.352

10.  PDX-1 interaction and regulation of the Pancreatic Derived Factor (PANDER, FAM3B) promoter.

Authors:  Brant R Burkhardt; Joshua R Cook; Robert A Young; Bryan A Wolf
Journal:  Biochim Biophys Acta       Date:  2008-07-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.